Related Experiment Videos
Management of anticoagulation before and after gastrointestinal endoscopy
Avelyn Kwok1, Douglas O Faigel
1Department of Gastroenterology, Concord Hospital, University of Sydney, Sydney, Australia.
Insights
Managing blood thinners before endoscopy requires balancing bleeding and clotting risks. This review covers guidelines and data for anticoagulant and antiplatelet therapy in gastrointestinal procedures.
Area of Science:
- Gastroenterology
- Cardiology
- Internal Medicine
Background:
- Managing anticoagulants and antiplatelet agents during gastrointestinal (GI) endoscopy is a frequent clinical challenge.
- Existing guidelines rely heavily on observational data and expert consensus rather than robust clinical trials.
Purpose of the Study:
- To review current data and guidelines for managing anticoagulant and antiplatelet therapy in patients undergoing GI endoscopic procedures.
- To discuss the use of reversal agents and the role of proton pump inhibitors in this context.
Main Methods:
- Literature review of observational studies, expert opinions, and available guideline recommendations.
- Analysis of risk-benefit balance between thromboembolism and bleeding.
Main Results:
- Guideline recommendations are primarily based on non-randomized data.
- Balancing thromboembolic risk against bleeding risk is the core principle for management decisions.
Conclusions:
- Individualized management plans are crucial for patients on anticoagulants or antiplatelet agents undergoing GI endoscopy.
- Understanding the risks associated with these medications and potential interventions is key to safe patient care.
Abstract:
The management of anticoagulants and antiplatelet agents in patients undergoing gastrointestinal endoscopic procedures is a common clinical problem. Although guidelines have been published, they are supported by little prospective or randomized trial data, but are primarily based on observational studies, expert opinion, and best clinical practices. As a general principle, the risks of thromboembolism need to be balanced against the risks of bleeding during the endoscopic procedure. By understanding these risks, management plans for individual cases may be made. This article reviews the current data and guidelines on the management of anticoagulants, antiplatelet agents, use of reversal agents, and the role and risks of concomitant proton pump inhibitors.
Related Concept Videos
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Aneurysm IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...